Literature DB >> 21686484

Symptomatic hypertrophic obstructive cardiomyopathy: semi-supine bicycle ergometry as a useful provocative manoeuvre to elicit latent gradient.

Sanjay Kumar Dhar1, Vatchsala Varadharajan, Abdallah Al-Mohammad, Julie Sandoval, Ever D Grech.   

Abstract

We report the case of a 58-year-old Caucasian woman with severe symptoms attributable to hypertrophic obstructive cardiomyopathy (HOCM). When supine there was no significant left ventricular outflow tract (LVOT) gradient on echocardiography or cardiac catheter measurements-despite provocation with supine leg exercise and right ventricular pacing. However, semi-supine bicycle exercise induced a marked increase in the LVOT gradient, which helped guide successful percutaneous alcohol septal ablation. This case report demonstrates the usefulness of bicycle exercise echocardiography in diagnosing HOCM with latent LVOT obstruction.

Entities:  

Year:  2009        PMID: 21686484      PMCID: PMC3027320          DOI: 10.1136/bcr.10.2008.1044

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy.

Authors:  F H Gietzen; C J Leuner; U Raute-Kreinsen; A Dellmann; J Hegselmann; C Strunk-Mueller; H J Kuhn
Journal:  Eur Heart J       Date:  1999-09       Impact factor: 29.983

2.  Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up.

Authors:  N M Lakkis; S F Nagueh; J K Dunn; D Killip; W H Spencer
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

3.  Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy.

Authors:  Waqar Shamim; Mohammed Yousufuddin; Duolao Wang; Michael Henein; Hubert Seggewiss; Marcus Flather; Andrew J S Coats; Ulrich Sigwart
Journal:  N Engl J Med       Date:  2002-10-24       Impact factor: 91.245

4.  Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.

Authors:  S F Nagueh; N M Lakkis; Z X He; K J Middleton; D Killip; W A Zoghbi; M A Quiñones; R Roberts; M S Verani; N S Kleiman; W H Spencer
Journal:  J Am Coll Cardiol       Date:  1998-07       Impact factor: 24.094

5.  Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy.

Authors:  P Boekstegers; P Steinbigler; A Molnar; M Schwaiblmair; A Becker; A Knez; R Haberl; G Steinbeck
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

6.  Left ventricular systolic dysfunction during exercise and dobutamine stress in patients with hypertrophic cardiomyopathy.

Authors:  K Okeie; M Shimizu; H Yoshio; H Ino; M Yamaguchi; T Matsuyama; T Yasuda; J Taki; H Mabuchi
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

7.  Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy, New York Heart Association functional class III or IV, and outflow obstruction only under provocable conditions.

Authors:  Frank H Gietzen; Christian J Leuner; Ludger Obergassel; Claudia Strunk-Mueller; Horst Kuhn
Journal:  Circulation       Date:  2002-07-23       Impact factor: 29.690

8.  Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes.

Authors:  S Firoozi; P M Elliott; S Sharma; A Murday; S J Brecker; M S Hamid; B Sachdev; R Thaman; W J McKenna
Journal:  Eur Heart J       Date:  2002-10       Impact factor: 29.983

9.  Dynamic intraventricular obstruction during dobutamine stress echocardiography. A new observation.

Authors:  P A Pellikka; J K Oh; K R Bailey; B A Nichols; K H Monahan; A J Tajik
Journal:  Circulation       Date:  1992-11       Impact factor: 29.690

10.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Iacopo Olivotto; Sandro Betocchi; Susan A Casey; John R Lesser; Maria A Losi; Franco Cecchi; Barry J Maron
Journal:  N Engl J Med       Date:  2003-01-23       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.